Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Shares Outstanding (Diluted Average) (2018 - 2025)

Historic Shares Outstanding (Diluted Average) for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $41.1 million.

  • Viemed Healthcare's Shares Outstanding (Diluted Average) rose 75.23% to $41.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.1 million, marking a year-over-year increase of 75.23%. This contributed to the annual value of $40.8 million for FY2024, which is 105.54% up from last year.
  • According to the latest figures from Q3 2025, Viemed Healthcare's Shares Outstanding (Diluted Average) is $41.1 million, which was up 75.23% from $41.4 million recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's Shares Outstanding (Diluted Average) ranged from a high of $41.6 million in Q1 2025 and a low of $39.8 million during Q4 2022
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $40.7 million (2021), whereas its average is $40.6 million.
  • In the last 5 years, Viemed Healthcare's Shares Outstanding (Diluted Average) plummeted by 236.86% in 2022 and then skyrocketed by 258.06% in 2025.
  • Over the past 5 years, Viemed Healthcare's Shares Outstanding (Diluted Average) (Quarter) stood at $40.7 million in 2021, then fell by 2.15% to $39.8 million in 2022, then grew by 1.44% to $40.4 million in 2023, then increased by 1.06% to $40.8 million in 2024, then grew by 0.69% to $41.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $41.1 million for Q3 2025, versus $41.4 million for Q2 2025 and $41.6 million for Q1 2025.